Array biopharma inc (ARRY)
Balance Sheet / Yearly
Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11
Assets
Current assets
Cash and cash equivalents

96,636

147,094

130,507

114,748

73,855

65,051

295,414

125,933

83,749

62,785

65,842

56,598

62,458

57,253

56,358

55,691

141,470

68,145

46,829

68,591

52,178

47,194

65,045

60,736

43,998

59,565

49,054

55,799

63,025

60,363

72,367

48,099

Marketable securities

326,452

329,964

283,886

297,739

364,555

354,221

168,093

108,390

122,996

151,147

50,810

53,344

55,398

62,631

102,944

122,635

48,600

73,416

63,873

42,407

57,714

72,481

58,126

47,505

42,583

49,616

18,279

33,378

36,411

360

4,855

15,986

Accounts receivable

31,660

22,245

44,378

32,084

44,158

29,970

26,601

31,279

32,507

43,122

33,938

39,302

62,921

64,782

13,504

6,307

2,116

4,878

6,000

5,429

4,433

5,710

1,014

9,595

-

-

-

1,075

-

-

-

-

Inventory

4,397

-

-

121

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

34,769

31,537

17,439

6,851

5,222

4,614

3,716

4,575

7,699

6,835

7,429

6,057

6,748

7,216

6,797

6,414

4,409

4,315

6,085

5,249

3,743

3,088

9,991

3,473

7,583

5,098

3,581

2,855

4,680

4,172

4,845

6,477

Total current assets

493,914

530,840

476,210

451,543

487,790

453,856

493,824

270,177

246,951

263,889

158,019

155,301

187,525

191,882

179,603

191,047

196,595

150,754

122,787

121,676

118,068

128,473

134,176

121,309

94,164

114,279

70,914

93,107

104,116

64,895

82,067

70,562

Non-current assets
Marketable securities

56,008

1,095

998

919

1,108

1,045

829

732

647

822

662

596

540

705

514

496

546

873

730

640

593

691

550

465

466

664

542

473

423

554

484

623

Property and equipment, net

6,977

6,902

6,860

7,128

7,554

7,206

7,579

8,132

8,488

7,442

7,251

6,680

6,498

5,694

4,988

5,050

7,455

8,072

7,764

8,157

7,838

8,421

9,144

10,049

10,720

11,245

11,717

12,059

12,931

13,994

14,797

15,698

Other non-current assets

10,105

10,125

151

774

555

738

77

104

116

49

929

6,323

1,621

1,637

1,647

1,614

3,849

3,949

4,047

6,152

8,656

8,736

8,775

4,165

2,081

2,185

2,318

2,434

2,570

2,709

2,428

2,491

Total non-current assets

73,090

18,122

8,009

8,821

9,217

8,989

8,485

8,968

9,251

8,313

8,842

13,599

8,659

8,036

7,149

7,160

11,850

12,894

12,541

14,949

17,087

17,848

18,469

14,679

13,267

14,094

14,577

14,966

15,924

17,257

17,709

18,812

Total assets

567,004

548,962

484,219

460,364

497,007

462,845

502,309

279,145

256,202

272,202

166,861

168,900

196,184

199,918

186,752

198,207

208,445

163,648

135,328

136,625

135,155

146,321

152,645

135,988

107,431

128,373

85,491

108,073

120,040

82,152

99,776

89,374

Liabilities and Stockholders' Equity
Current liabilities
Accounts payable

9,128

10,420

14,609

14,059

11,723

10,996

8,881

8,636

7,758

6,454

5,921

10,147

15,568

12,110

6,478

4,570

7,616

9,264

5,216

6,953

7,020

3,958

3,072

5,396

7,506

4,726

4,309

6,466

4,593

4,948

4,521

4,460

Accrued outsourcing costs

39,359

41,535

34,264

31,853

34,334

27,301

37,533

31,388

30,608

29,053

25,554

19,140

23,222

20,481

17,659

17,402

14,936

14,188

13,709

10,040

8,036

7,356

6,350

5,576

5,060

4,509

4,448

5,394

5,798

4,371

4,587

5,248

Accrued compensation and benefits

16,444

14,105

17,194

16,695

10,345

6,772

12,185

10,172

7,437

5,389

10,154

8,633

6,713

5,635

8,764

7,507

6,677

4,910

9,419

8,209

7,221

5,414

10,028

9,481

7,673

5,098

9,172

7,530

5,661

4,759

7,508

6,431

Other accrued expenses

7,319

4,639

6,550

1,868

2,779

1,754

2,617

1,575

2,373

1,167

1,942

1,068

2,356

2,266

3,549

2,714

2,034

2,709

3,127

1,444

2,170

1,633

2,353

1,135

1,434

1,896

1,955

1,390

8,898

7,921

6,358

2,312

Co-development liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

25,019

14,953

16,155

11,967

6,690

12,204

10,990

6,994

3,970

10,098

9,178

-

-

-

-

Deferred rent

783

725

724

707

689

671

640

624

614

605

596

590

630

670

991

1,285

3,856

3,800

3,763

3,739

3,717

3,695

3,686

3,646

3,606

3,567

3,528

3,489

3,450

3,411

3,372

3,333

Notes payable at fair value

0

0

0

15,899

12,800

12,700

12,400

0

12,100

10,800

10,200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

13,627

12,761

11,425

12,350

12,419

13,419

16,669

17,156

10,360

10,917

9,846

12,856

10,991

11,858

11,820

8,946

9,798

8,049

6,382

6,193

5,733

9,532

14,193

14,353

21,865

26,534

33,107

42,339

47,147

54,468

62,479

47,874

Current portion of long-term debt

0

0

0

2,500

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

150

150

150

150

4,350

150

Total current liabilities

86,660

84,185

84,766

95,931

85,089

73,613

90,925

69,551

71,250

64,385

64,213

52,434

59,480

53,020

49,261

42,424

44,917

67,939

56,569

52,733

45,864

38,278

51,886

50,577

54,138

50,300

66,767

75,936

75,697

80,028

93,175

69,808

Non-current liabilities
Co-development liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,696

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

5,216

5,252

5,414

5,598

5,783

5,766

5,610

5,714

5,881

4,662

4,462

4,184

3,609

3,038

3,163

3,314

1,184

2,156

3,125

4,096

5,032

5,967

6,887

7,834

8,747

9,661

10,572

11,480

12,353

13,227

14,100

14,968

Deferred revenue

38,312

40,231

42,635

44,470

44,945

46,821

54,886

57,325

31,179

32,737

34,295

35,961

35,359

26,895

900

2,040

3,662

0

2,525

3,353

4,329

5,305

6,281

0

725

4,569

10,322

13,228

18,704

24,766

37,069

39,306

Long-term debt, net

134,245

132,654

131,093

93,376

94,555

93,264

123,266

121,305

119,394

117,544

115,353

-

111,999

110,386

108,813

107,280

107,985

106,607

105,263

101,524

102,675

101,430

100,203

99,021

95,349

94,417

93,178

92,106

90,900

90,036

88,259

91,390

Notes payable at fair value

-

-

-

-

0

0

0

12,600

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

421

479

527

-

733

734

526

540

Other non-current liabilities

946

1,289

1,243

1,246

1,485

1,199

1,001

923

784

822

662

598

540

705

514

496

546

873

730

640

593

691

550

465

466

664

542

1,129

423

554

484

4,220

Total non-current liabilities

178,719

179,426

180,385

144,690

146,768

147,050

184,763

197,867

157,238

155,765

154,772

154,398

151,507

141,024

113,390

113,130

113,377

109,636

116,339

109,613

112,629

113,393

113,921

107,320

105,708

109,790

115,141

117,943

123,113

129,317

140,438

150,424

Total liabilities

265,379

263,611

265,151

240,621

231,857

220,663

275,688

267,418

228,488

220,150

218,985

206,832

210,987

194,044

162,651

155,554

158,294

177,575

172,908

162,346

158,493

151,671

165,807

157,897

159,846

160,090

181,908

193,879

198,810

209,345

233,613

220,232

Commitments and contingencies

-

-

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders' equity
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

8,054

-

-

-

-

Common stock, $0.001 par value; 340,000,000 and 280,000,000 shares authorized as of March 31, 2019 and June 30, 2018, respectively, 221,548,492 and 211,289,922 shares issued and outstanding as of March 31, 2019 and June 30, 2018, respectively

221

218

213

211

210

207

196

171

170

169

147

144

143

143

142

142

140

139

132

132

126

125

121

117

117

117

95

92

89

62

57

57

Additional paid-in capital

1,440,913

1,387,422

1,309,985

1,286,000

1,279,256

1,233,359

1,183,122

930,293

916,699

905,249

777,733

763,324

761,433

759,486

753,496

751,073

696,661

687,226

653,910

652,696

626,843

619,907

595,683

571,270

523,109

522,214

446,608

437,401

428,004

357,902

347,458

346,853

Warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

39,385

39,385

39,385

39,385

39,385

39,385

39,385

39,385

39,385

39,385

39,385

39,385

39,385

39,385

39,385

39,385

Accumulated other comprehensive income (loss)

165

-109

-312

-461

-757

-676

-42

-76

-86

-50

11

7

14

-37

17

5

9,798

13,463

14,522

2

7

0

8

-2

2

2

-

-1

-1

-

-1

3

Accumulated deficit

-1,139,674

-1,100,000

-1,090,818

-1,066,007

-1,013,559

-990,708

-956,655

-918,661

-889,069

-853,316

-830,015

-801,407

-776,393

-753,718

-729,554

-708,567

-695,833

-754,140

-745,529

-717,936

-689,699

-664,767

-648,359

-632,679

-615,028

-593,435

-582,505

-570,737

-562,710

-554,542

-550,736

-547,156

Total stockholders' equity

301,625

285,351

219,068

219,743

265,150

242,182

226,621

11,727

27,714

52,052

-52,124

-37,932

-14,803

5,874

24,101

42,653

50,151

-13,927

-37,580

-25,721

-23,338

-5,350

-13,162

-21,909

-52,415

-31,717

-96,417

-85,806

-78,770

-127,193

-133,837

-130,858

Total liabilities and stockholders' equity

567,004

548,962

484,219

460,364

497,007

462,845

502,309

279,145

256,202

272,202

166,861

168,900

196,184

199,918

186,752

198,207

208,445

163,648

135,328

136,625

135,155

146,321

152,645

135,988

107,431

128,373

85,491

108,073

120,040

82,152

99,776

89,374